SGP SpyGlass Pharma, Inc.
Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1778922 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-33.5%
ROA-31.1%
ROIC (approx.)-3,475.3%
Asset turnover—
Leverage & solvency
Liabilities / assets7.0%
Debt / equity0.00x
Current ratio15.24x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.76x
Accruals ratio-7.4%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | — | — |
| R&D expense | $29.18M | $19.98M |
| SG&A expense | $12.27M | $7.08M |
| Operating income | -$41.45M | -$27.06M |
| Pretax income | -$39.87M | -$29.16M |
| Income tax | $0 | $0 |
| Net income | -$39.87M | -$29.16M |
| EBITDA | -$40.84M | -$26.79M |
| EPS (basic) | -17.98 | -16.31 |
| EPS (diluted) | -17.98 | -16.31 |
| Weighted avg. shares (diluted) | 2.22M | 1.79M |
| Balance sheet | ||
| Cash & equivalents | $96.36M | $16.27M |
| Current assets | $108.77M | $17.41M |
| PP&E, net | $2.34M | $2.17M |
| Total assets | $115.87M | $23.32M |
| Current liabilities | $8.58M | $7.79M |
| Total liabilities | $10.17M | $11.25M |
| Shareholders' equity | -$98.84M | -$60.47M |
| Shares outstanding | 2.20M | 2.20M |
| Cash flow statement | ||
| Operating cash flow | -$32.70M | -$22.03M |
| Capital expenditure | $789,000 | $1.99M |
| Free cash flow | -$33.49M | -$24.02M |
| Investing cash flow | -$11.79M | $22.26M |
| Financing cash flow | $124.58M | $185,000 |
| Depreciation & amortization | $612,000 | $271,000 |
| Stock-based compensation | $2.79M | $1.49M |
| Share buybacks | $1.45M | $0 |
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.